Diabetes is one of the leading diseases worldwide and, thus, finding new therapeutic alternatives is essential. The development of Non-alcoholic Fatty Liver Disease is a notable diabetic complication. Therefore, antioxidant therapy became a leading topic in the world of diabetes research. The objective of this present study was to evaluate the effects of antioxidant N-Acetyl-cysteine (NAC) administration on serum biochemical parameters and oxidative stress parameters in hepatic tissue of the diabetic rats. 32 animals were divided in 4 groups (n=8), G1: Normal rats, G2: Normal rats + NAC, G3: Diabetic rats, and G4: Diabetic rats + NAC. Diabetes was induced in diabetic groups through streptozotocin.
D r a f t D r a f t
Introduction
Considering insulin's important metabolic role as a suppressor of lipolysis in adipose tissue, hypoinsulinemia in diabetes mellitus type 1 (DM1) leads to an increased release of free fatty acids (FFA) in the bloodstream (Adiels et al. 2008 ) and influx of acids to the liver. This contributes to increased β-oxidation, producing more acetyl-CoA, NADH and FADH 2 comparatively to glycolytic process (Leverve 2007) , leading to D r a f t increased oxidative phosphorylation, which favors electron leakage and mitochondrial reactive oxygen species (ROS) generation (Kowaltowski et al. 2009 ).
Intrahepatic triglycerides (TG) accumulation happens when the influx of lipids to the liver exceeds the hepatic capacity to export TG to the bloodstream (Adiels et al. 2008 ).
These conditions are ideal for the development of hepatic steatosis that includes the initial phase of Non-Alcoholic Fatty Liver Disease (NAFLD), one of the most relevant diabetic complications, with prevalence around 19% to 46%, and approximately of 50% in patients with type 1 diabetes (Cusi et al. 2017) .
Studies show the importance of oxidative stress (imbalance between production and neutralization of reactive oxygen species (ROS)) as one of the mechanisms that aggravate NAFLD in the diabetes (Rolo et al. 2012; Ucar et al. 2013) . TG accumulated in liver and phospholipids of cellular membranes can be targeted by ROS, leading to lipid peroxidation, alteration in the structure and permeability of membranes and consequently mitochondrial dysfunction (Vamecq et al. 2012) , favoring ROS production further (Sarkhail et al. 2007) . Diabetic hyperglycemia can also increase ROS production, by formation of Advanced glycation end products (AGEs), glucose autooxidation, increased activity of polyol pathway and suppression of antioxidants system (Fiorentino et al. 2013) .
Another finding in the relation between diabetes and oxidative stress is the decrease of antioxidant enzyme activity, decreasing cellular ability to neutralize ROS, exacerbating oxidative stress (Sarkhail et al. 2007; Trivedi et al. 2014 ). There are indications that the glutathione (GSH) enzymatic system (glutathione peroxidase (GSH-Px), reductase (GSR) and transferase (GST)) is also impaired in the DM, as well as diminished D r a f t 4 availability of reduced GSH, which is a substrate for GSH-Px (Ruffmann and Wendel 1991; Santos et al. 2014) .
In this context, therapeutic strategies with the use of natural products with antioxidant and hypoglycemic properties have been the focus of several studies (Bajaj and Khan 2012; Abdali, Samson and Grover 2015; Öztürk et al 2017) . N-acetyl-cysteine (NAC) is an antioxidant commonly found in Allium plants like garlic and onion, and contains cysteine in its composition, an essential precursor during the synthesis of reduced GSH, which has a key role in antioxidant defense as the substrate for GSH-Px (Ruffmann and Wendel 1991) . Hence, NAC has the capacity of restoring intracellular reduced GSH levels (Suzuki 2009) . There is evidence that NAC neutralize ROS by reducing them directly through its thyol group (Samuni et al. 2013 ).
Studies have reported positive effects of NAC administration on kidney and liver of diabetic rats (Hsu et al. 2004; Ribeiro et al. 2011 ), but some still show conflicting results (de Bairros et al. 2013; Patriarca et al. 2005) . Although the literature reports improvement in both hypoinsulinemia and hyperglycemia with the administration of NAC (Hsu et al. 2004; Kamboj et al. 2010) , there are still few studies addressing the influence of NAC on hepatic steatosis caused by DM1.
Thus, the objective of this study was to evaluate the effects of NAC administration on serum and hepatic biochemical parameters, TG accumulation and oxidative stress through the activity of antioxidant enzymes and important biomarkers of oxidative stress in the liver of diabetic rats.
Material & Methods

Experimental groups and maintenance
The animal experiment was conducted with approval of the Ethical Committee on the Use of Animals (CEUA) at the Institute of Biosciences of Botucatu, São Paulo State University (UNESP), under protocol number 706, and followed the guidelines highlighted by the Guide for the Care and Use of Laboratory Animals (8 th edition). A total of 32 male Wistar rats (± 250g b.w.) with 60 days of age were housed in polypropylene cages in an environment with temperature (23 ± 2ºC) and relative humidity (55 ± 5 %) controlled, and 12 hours light/dark cycle. Animals were randomly divided into four groups of 8 animals in each: G1, control normal rats; G2, normal rats treated with NAC; G3, diabetic rats and G4, diabetic rats treated with NAC.
The experimental diabetes was induced with streptozotocin (STZ) administration at 60 mg kg -1 b.w (single dose, ip.), diluted in 0.1 M sodium citrate buffer, pH 4.5. After 28 hours of administration of STZ, diabetes was confirmed in animals with glycemia above 250 mg dL -1 according to Santos et al. (2014) . NAC (sigma® A7250) was administered at the concentration of 25 mg kg -1 b.w. day -1 , orally via gavage, for 37 days (Ribeiro et al., 2011) .
The animals received water and standard rodent chow (Purina, Campinas, Brazil), which contained 22.0 % protein, 3,8 % fat, 44.5 % carbohydrate and 3.0 kcal/g of metabolizable energy. The control of intake water and food was daily between 9:00-10:00h am. Body weight was measured at interval of 7 days.
Serum and hepatic biochemical analysis
After 37 days of experimental period, animals were fasted overnight (12-14 h), anesthetized with ketamine chloride and xylazine chloride (solution 2:1) and euthanized by decapitation. The blood was centrifuged at 1,400 g/10 min to obtain the serum.
Glycemia was determined by colorimetric method in the presence glucose oxidase and peroxidase (test kit diagnostic LABTEST, Minas Gerais, Brasil. Serum concentration of insulin was determination by enzyme immune assay kit (EIA kit, Cayman Chemical, USA). Serum FFA were extracted, in medium containing chloroform, heptane and methanol, and determined according to the method described by Regouw et al. (1971) .
The activity of alanine aminotransferase (ALT) was measured by the rate of oxidation of NADH, which was proportional to activity of enzyme (Wilkinson 1965) . .cm − 1 the concentration of PC was quantified at 360 nm according to method based in formation the of Schiff base described by Reznick and Packer (1994) .
Glutathione reductase (GSR) and reduced glutathione (GSH) were assayed in sodium phosphate buffer 100mM; pH 7.4 with DTNB (5,5' -dithiobis-2-nitrobenzoic acid), NADPH, GSR and EDTA (ethylenediaminetetraacetic acid). Total GSH was measured in medium containing Tris-HCl buffer (0.1 M, pH 8.0), DTNB, GSR and EDTA (Tietze 1969 ). Through of nitro blue tetrazolium (NBT) reduction analyzed the superoxide dismutase (SOD) activity in the presence 50 mM sodium phosphate buffer pH 7.4, EDTA phenazine methosulfate and NADH according to the method described by Ewing and Janero (1995) . Catalase (cat) activity was determined using sodium and potassium phosphate buffer (50 mM, pH 7.0) and hydrogen peroxide (Aebi 1974) . GSH-Px activity was measured by NADPH oxidation in sodium phosphate buffer 0.15 M, pH 7.0 containing NADPH, GSR, reduced GSH, sodium azide and EDTA (Nakamura et al. 1974 ).
Glutathione transferase (GST) activity was assayed utilizing 1,2 -dichloro-4-nitrobenzene (CDNB) as substrate in reaction mixture with 0.1 M potassium phosphate pH 6.5 and reduced GSH (Habig et al. 1974 ).
Another sample of hepatic tissue (approximately 100 mg) was used for determination of concentration of TG. The extraction of total lipid took place through homogenization in mixture containing chloroform:methanol (2:1; v/v) (Bligh and Dyer 1959). In the chloroform layer, separated after 24 hours, quantified the level of TGs, using the enzymatic method with formation of the quinoneimine, which is directly proportional to the TG present in the sample (Moura 1982) .
The values of absorbance as well as enzymatic activity were obtained in ELISA reader (µQuant-MQX/Bio-tech Instruments, Inc., USA) with monitored readings by Gen5 2.0 software to computer system.
Statistical analysis
Data was evaluated by analysis of variance (ANOVA) and Tukey test for comparison between the averages of the experimental groups. Statistically significant differences were considered when P values <0.05 (Zar 1996) . Glycemia significantly increased in untreated diabetic rats (G3) when compared to other groups (G1, G2 and G4), while insulin levels decreased in G3. Diabetic rats treated with NAC (G4) improved these parameters, with lower glycemia and higher insulin levels, but not returning to the same levels of the non-diabetic (G1 and G2) rats. The levels of serum urea were increased by the diabetic condition in G3, and decreased by the treatment with NAC in G4. The level of serum FFAs was increased in G3 group and reduced in G4 group (Table 1) .
Results
Hyperglycemia, hypoinsulinemia
Liver Injury hepatotoxicity
Hepatic TG accumulation was higher in G3, and significantly reduced by NAC administration in STZ-induced diabetic rats (G4) ( Table 1) .
Untreated diabetic rats (G3) had higher serum concentration of urea and ALT activity than the others groups (Table 2) . Treatment with NAC was capable of reducing the concentration and ALT activity, but not enough to return them to normality. (Table 2) Hepatic oxidative stress biomarkers Figure 1 shows the data for hepatic oxidative stress biomarkers. LH and PC level was highest in G3 group, but was normalized by NAC administration, returning to nondiabetic levels.
G3 group had lower total and reduced GSH concentration. Note that there were no significant alterations in total GSH among the groups G1, G2 and G4.
GSR and GST activities were decreased in STZ-induced diabetic rats (G3), whereas NAC administration enhanced GR activity and normalized GT activity in G4 group. Table 3 shows that catalase activity decreased in the diabetic rats (G3 group) in comparison to the non-diabetic (G1 and G2), whereas no significant difference was found with NAC treatment in STZ-induced diabetic rats (G4 group).
Hepatic antioxidant enzymes activity
Treatment in G4 group, compared with untreated G3 group, normalized SOD and GSHPx activities. NAC was effective, increasing the antioxidant activity that was depressed by diabetes in G3, restoring it to activity levels of the non-diabetic groups (G1 and G2). Since insulin is responsible for the entry of glucose into the cell, low insulin leads to hyperglycemia in STZ-diabetic rats (G3). There is an association between poor glycemic and increase circulating FFA in diabetic state (Oliveira et al. 2013 Others studies showed that hepatic steatosis is a prevalent pathological condition among DM1 patients (Regnell and Lernmark (2011) and in experimental diabetes (Tahara et al. 2014 ).
In present study, this pathological accumulation of TG may have caused a certain degree of liver injury, as observed by marked increase in the activities of ALT and GST in STZ-diabetic rats (G3). These observations are in agreement with Donelly et al.
(2005) that demonstrated hepatic injury during the ectopic accumulation of TG in hepatocyte. Serum increase of both ALT and GST activity was utilized as biomarkers of liver injury status in experimental models (Cachón et al. 2016; Liu et al. 2014 ).
In addition, the high serum concentration of urea detected in G3 can be attributed to the special metabolism in diabetic condition, where there is excessive oxidative degradation of amino acid whose carbon skeletons are utilized as precursors for gluconeogenesis (Postic et al. 2004) .
The administration of NAC in diabetic rats (G4) restored the level insulin and controlled the hyperglycemia. These results can be attributed to greater glucose uptake and utilization by peripheral and hepatic tissues. The increase of insulin levels by NAC- Under the pathological aspect, the NAFLD presents "two hits". The first hit involves TG accumulation which contributes to oxidative stress in liver (second hit) (Day, 2011).
Excessive formation of ROS in detriment to system endogenous antioxidant system results in oxidative stress (Baydas et al. 2002 In the present study, the TG deposition may have caused elevation of the biomarkers in the hepatic tissue of G3, since lipotoxicity is a contributing factor to oxidative stress.
Exacerbated accumulation of TG in the liver, mainly ceramide, makes the cell more susceptible to oxidative stress by promoting ROS generation, as described previously 
2000
; Aruoma et al. 1989; Lasram et al. 2015; Pastor et al. 1997; Samuni et al. 2013 ).
The hepatic concentrations of total and reduced GSH as well as GSR and GST activity were diminished in STZ-induced diabetic rats (G3). These results can be explained by the polyol pathway.
Under the diabetic state, reduced GSH is commonly depleted (Ruffmann and Wendel 1991) , which leads to low activity of GSH-Px (catalyzes the reduction of hydrogen peroxide to water), impairing the ability the cell to neutralize ROS and thus promoting oxidative stress (Jurkovic et al. 2008) . This depletion occur during the stimulation of the polyol pathway, which is one of the mechanisms whereby the hyperglycemia can lead to oxidative stress -the accumulated glucose in blood activates aldose reductase, which converts glucose into sorbitol and oxidizes NADPH (Antony and Vijayan 2015) . Since glutathione reductase requires NADPH as coenzyme for reducing the oxidized form of glutathione (GSSG) into reduced form, during polyol pathway stimulation, the concentration of GSH decreases, hence compromising the activity of both GSH-Px and GST.
The treatment with NAC was able to correct the alterations observed in the GSH system and improved antioxidant status in liver of STZ-diabetic rats through regeneration in GST, GSR and GSH-Px activities, as well as the levels of both total and reduced GSH.
Therefore, the antioxidant property of NAC resides in its capacity to restore the intracellular content of GSH in hepatic tissue (Ribeiro et al. 2011) . It is well known fact that GSH plays an important role in antioxidant defense because it acts as substrate of the GSH-Px and glutathione transferase, which are involved in the endogenous antioxidant system, maintaining redox homeostasis in the cell (Suzuki. 2009; Hayes et al. 2005; Ruffmann and Wendel 1991) . Furthermore, increased GSH-Px activity can be attributed to greater synthesis and consequently restoration of GSH levels, substrate of the enzyme, in hepatic tissue of diabetic rats treated with NAC (G4 group).
The relevance of this study was to demonstrate the importance of NAC supplementation in the control of oxidative stress caused by hepatic steatosis, one of the pathogenesis of DM1.
D r a f t
Conclusions
In conclusion, DM1 was associated with oxidative stress due accumulation of TGs in the liver. NAC intake promoted the release of insulin, ameliorated hyperglycemia, attenuated the hepatic exacerbated deposit of TG and consequently the oxidative stress, as shown by diminished biomarkers and increased activities of antioxidants enzymes.
Considering the important role of oxidative stress in the development of diabetic complications and in the progression of the disease, the beneficial effect of NAC on liver is likely as a result of its antidiabetogenic and antioxidant properties. D r a f t Table 1 . Glycemia, serum insulin, serum urea, FFA and TG concentration in hepatic tissue.
Parameters
Groups
G1
G2 G3 G4
Glycemia(mg mL -1 ) 92,71 ± 14,41a 98,10 ± 14,07a 351,0 ± 27,94c 128,8 ± 12,87b Insulin (ng mL -1 )
2,02 ± 0,27c 2,21 ± 0,30c 0,49 ± 0,14a 1,09 ± 0,15b
Urea (mg mL -1 ) 37,63 ± 3,62 a 30,19 ± 5,27a 114,19 ± 12,68c 75,25 ± 7,00b FFA (mEq L -1 ) Cat (µmol/g tissue) 48,54 ± 9,95b 55,31 ± 7,66b 32,31 ± 7,78a 44,25 ± 9,53ab SOD (nmol/mg pt)
27,05 ± 1,51b 28,64 ± 3,99b 20,00 ± 3,17a 25,07 ± 2,47b
GSH-Px (nmol/mg tissue) 138,64 ± 14,86b 138,17 ± 10,32b 113,87 ± 20,95a 137,56 ± 11,13b Cat: catlase; SOD: superoxide dismutase; GSH-Px: glutathione peroxidase. G1: control; G2: NAC 25mg 
